Bank of Montreal’s veteran oil and gas analyst is making the case for a four-way mega merger in Western Canada’s Montney ...

Protagonist Therapeutics (NASDAQ:PTGX – Get Free Report) had its target price boosted by equities researchers at BMO Capital ...

U.S. government debt rallied aggressively overnight and into Tuesday’s trading session, pushing yields below key technical levels in a way that appeared to be shaking confidence in the broader market.

Stock analysts at BMO Capital Markets started coverage on shares of Dyne Therapeutics (NASDAQ:DYN – Get Free Report) in a ...

BMO Capital Markets initiated coverage on Dyne Therapeutics (DYN, Financials) with an Outperform rating and a $50 price target, suggesting a strong upside from the company's current share price of ...

On Thursday, BMO Capital Markets sustained their Market Perform rating on Casey’s General Stores (NASDAQ:CASY), with a steady price target of $450.00. The convenience store chain, currently ...

BMO Capital raised the firm’s price target on Okta (OKTA) to $130 from $105 and keeps a Market Perform rating on the shares. The firm had been ...

BMO Capital analyst Keith Bachman initiated coverage of SailPoint (SAIL) with an Outperform rating and $26 price target The firm believes ...